United States Clotting Factor Market Report 2016

October 2016 | 123 pages | ID: U27CC4C4DDAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Clotting Factor

Revenue, means the sales value of Clotting Factor

This report studies sales (consumption) of Clotting Factor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals, Inc. (US)
• GlaxoSmithKline (UK)
• AbbVie, Inc. (US)
• Anavex Life Sciences Corp. (US)
• Baxter International, Inc. (US)
• Biocon (India)
• Eli Lilly (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Genentech (US)
• Janssen Biotech, Inc. (US)
• Kemwell Biopharma (India)
• Novartis (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Sanofi S.A. (France)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Clotting Factor in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Clotting Factor Market Report 2016

1 CLOTTING FACTOR OVERVIEW

1.1 Product Overview and Scope of Clotting Factor
1.2 Classification of Clotting Factor
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Clotting Factor
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Clotting Factor (2011-2021)
  1.4.1 United States Clotting Factor Sales and Growth Rate (2011-2021)
  1.4.2 United States Clotting Factor Revenue and Growth Rate (2011-2021)

2 UNITED STATES CLOTTING FACTOR COMPETITION BY MANUFACTURERS

2.1 United States Clotting Factor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Clotting Factor Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Clotting Factor Average Price by Manufactures (2015 and 2016)
2.4 Clotting Factor Market Competitive Situation and Trends
  2.4.1 Clotting Factor Market Concentration Rate
  2.4.2 Clotting Factor Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CLOTTING FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Clotting Factor Sales and Market Share by Type (2011-2016)
3.2 United States Clotting Factor Revenue and Market Share by Type (2011-2016)
3.3 United States Clotting Factor Price by Type (2011-2016)
3.4 United States Clotting Factor Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CLOTTING FACTOR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Clotting Factor Sales and Market Share by Application (2011-2016)
4.2 United States Clotting Factor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CLOTTING FACTOR MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Clotting Factor Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals, Inc. (US)
  5.2.2 Clotting Factor Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline (UK)
  5.3.2 Clotting Factor Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline (UK) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 AbbVie, Inc. (US)
  5.4.2 Clotting Factor Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 AbbVie, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Anavex Life Sciences Corp. (US)
  5.5.2 Clotting Factor Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Anavex Life Sciences Corp. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Baxter International, Inc. (US)
  5.6.2 Clotting Factor Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Baxter International, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Biocon (India)
  5.7.2 Clotting Factor Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Biocon (India) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Eli Lilly (US)
  5.8.2 Clotting Factor Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Eli Lilly (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 F. Hoffmann-La Roche Ltd. (Switzerland)
  5.9.2 Clotting Factor Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Genentech (US)
  5.10.2 Clotting Factor Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Genentech (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Janssen Biotech, Inc. (US)
5.12 Kemwell Biopharma (India)
5.13 Novartis (Switzerland)
5.14 Sun Pharmaceutical Industries Ltd. (India)
5.15 Sanofi S.A. (France)

6 CLOTTING FACTOR MANUFACTURING COST ANALYSIS

6.1 Clotting Factor Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Clotting Factor

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Clotting Factor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Clotting Factor Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CLOTTING FACTOR MARKET FORECAST (2016-2021)

10.1 United States Clotting Factor Sales, Revenue Forecast (2016-2021)
10.2 United States Clotting Factor Sales Forecast by Type (2016-2021)
10.3 United States Clotting Factor Sales Forecast by Application (2016-2021)
10.4 Clotting Factor Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Clotting Factor
Table Classification of Clotting Factor
Figure United States Sales Market Share of Clotting Factor by Type in 2015
Table Application of Clotting Factor
Figure United States Sales Market Share of Clotting Factor by Application in 2015
Figure United States Clotting Factor Sales and Growth Rate (2011-2021)
Figure United States Clotting Factor Revenue and Growth Rate (2011-2021)
Table United States Clotting Factor Sales of Key Manufacturers (2015 and 2016)
Table United States Clotting Factor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Clotting Factor Sales Share by Manufacturers
Figure 2016 Clotting Factor Sales Share by Manufacturers
Table United States Clotting Factor Revenue by Manufacturers (2015 and 2016)
Table United States Clotting Factor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Clotting Factor Revenue Share by Manufacturers
Table 2016 United States Clotting Factor Revenue Share by Manufacturers
Table United States Market Clotting Factor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Clotting Factor Average Price of Key Manufacturers in 2015
Figure Clotting Factor Market Share of Top 3 Manufacturers
Figure Clotting Factor Market Share of Top 5 Manufacturers
Table United States Clotting Factor Sales by Type (2011-2016)
Table United States Clotting Factor Sales Share by Type (2011-2016)
Figure United States Clotting Factor Sales Market Share by Type in 2015
Table United States Clotting Factor Revenue and Market Share by Type (2011-2016)
Table United States Clotting Factor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Clotting Factor by Type (2011-2016)
Table United States Clotting Factor Price by Type (2011-2016)
Figure United States Clotting Factor Sales Growth Rate by Type (2011-2016)
Table United States Clotting Factor Sales by Application (2011-2016)
Table United States Clotting Factor Sales Market Share by Application (2011-2016)
Figure United States Clotting Factor Sales Market Share by Application in 2015
Table United States Clotting Factor Sales Growth Rate by Application (2011-2016)
Figure United States Clotting Factor Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Clotting Factor Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Clotting Factor Sales Market Share (2011-2016)
Table GlaxoSmithKline (UK) Basic Information List
Table GlaxoSmithKline (UK) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline (UK) Clotting Factor Sales Market Share (2011-2016)
Table AbbVie, Inc. (US) Basic Information List
Table AbbVie, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie, Inc. (US) Clotting Factor Sales Market Share (2011-2016)
Table Anavex Life Sciences Corp. (US) Basic Information List
Table Anavex Life Sciences Corp. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anavex Life Sciences Corp. (US) Clotting Factor Sales Market Share (2011-2016)
Table Baxter International, Inc. (US) Basic Information List
Table Baxter International, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International, Inc. (US) Clotting Factor Sales Market Share (2011-2016)
Table Biocon (India) Basic Information List
Table Biocon (India) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon (India) Clotting Factor Sales Market Share (2011-2016)
Table Eli Lilly (US) Basic Information List
Table Eli Lilly (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly (US) Clotting Factor Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Clotting Factor Sales Market Share (2011-2016)
Table Genentech (US) Basic Information List
Table Genentech (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech (US) Clotting Factor Sales Market Share (2011-2016)
Table Janssen Biotech, Inc. (US) Basic Information List
Table Janssen Biotech, Inc. (US) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech, Inc. (US) Clotting Factor Sales Market Share (2011-2016)
Table Kemwell Biopharma (India) Basic Information List
Table Kemwell Biopharma (India) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kemwell Biopharma (India) Clotting Factor Sales Market Share (2011-2016)
Table Novartis (Switzerland) Basic Information List
Table Novartis (Switzerland) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis (Switzerland) Clotting Factor Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List
Table Sun Pharmaceutical Industries Ltd. (India) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Clotting Factor Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Clotting Factor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Clotting Factor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Clotting Factor
Figure Manufacturing Process Analysis of Clotting Factor
Figure Clotting Factor Industrial Chain Analysis
Table Raw Materials Sources of Clotting Factor Major Manufacturers in 2015
Table Major Buyers of Clotting Factor
Table Distributors/Traders List
Figure United States Clotting Factor Production and Growth Rate Forecast (2016-2021)
Figure United States Clotting Factor Revenue and Growth Rate Forecast (2016-2021)
Table United States Clotting Factor Production Forecast by Type (2016-2021)
Table United States Clotting Factor Consumption Forecast by Application (2016-2021)